Search All UT System Experts

New HER2-directed therapies for breast cancer: Commentary re: C. I. Spiridon et al., Targeting multiple HER-2 epitopes with monoclonal antibodies results in improved antigrowth activity. Clin. Cancer Res., 8: 1720-1730, 2002

Arthur E. Frankel

Research output: Contribution to journal › Comment/debate › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'New HER2-directed therapies for breast cancer: Commentary re: C. I. Spiridon et al., Targeting multiple HER-2 epitopes with monoclonal antibodies results in improved antigrowth activity. Clin. Cancer Res., 8: 1720-1730, 2002'. Together they form a unique fingerprint.